Non Hodgkin's lymphoma (NHL)

Non Hodgkin’s lymphoma (NHL) is a group of similar types of cancer that start in the lymph nodes and lymphatic system. Find out about symptoms, risk factors and causes, diagnostic tests, treatment, including surgery, chemotherapy, radiotherapy and biological therapy, likely outcome (prognosis), research and clinical trials, and how to cope with NHL including managing after a stem cell transplant and how lymphoma may affect your sex life.

CR PDF Icon View a summary of this section

What to ask your doctor

CR PDF Icon View a summary of this section

You can also find non Hodgkin's lymphoma organisations providing help and support, a reading list and see where this information comes from.

Did you know that Cancer Research UK has an online forum for people affected by cancer? Cancer Chat is your space to talk about cancer.

Plus join the Q & A sessions on the first Thursday of every month and have your questions answered by one of our cancer specialist nurses.

News: B-cell lymphoma discovery could lead to new treatments: A protein called can CD19 help drive a form of non-Hodgkin's lymphoma called B-cell lymphoma, rather than just being a 'marker' for the disease, according to US scientists.; 1 May 2012
News: Trial finds new drug combo increases remission time for lymphoma patients: A trial led by French researchers has found that patients under 60 with a form of non-Hodgkin's lymphoma called 'diffuse large B-cell lymphoma' are more likely to have a longer remission if they were given a combined treatment of the drug rituximab with a more intensive regimen of chemotherapy.; 25 Nov 2011
News: NICE approves rituximab as maintenance therapy for non-Hodgkin's lymphoma: The National Institute for Health and Clinical Excellence (NICE) has published draft guidance recommending rituximab as a maintenance therapy for certain patients with follicular non-Hodgkin's lymphoma.; 25 May 2011

News: News digest – ‘stratified’ medicine, government reforms, and improving survival rates: There’s been another glut of fascinating stories this week, most of which focused on aspects of the NHS. Here’s our digest – follow the links for the full story: On Monday, we announced that we’d enrolled the first patients into … Continue reading →; 26 Nov 2011
News: Is ecstasy ‘being developed to treat blood cancers’? Not quite…: Here are a few thoughts on this morning’s headlines about ecstasy and cancer. (In case you missed them, they’re based on research from Birmingham, published in the New Investigational Drugs journal, in which researchers report that they’ve ‘redesigned’ the molecular … Continue reading →; 19 Aug 2011
News: NCRI Cancer Conference 2009: A new dawn – Monoclonal antibodies: There are so many different types of cancer drugs coming into the clinic that it can sometimes be hard to keep up. Among the most exciting additions in the last decade are monoclonal antibodies (mAbs) – Herceptin and rituximab are … Continue reading →; 6 Nov 2009